Old Web
English
Sign In
Acemap
>
authorDetail
>
Kristi Mclendon
Kristi Mclendon
Royal Brisbane and Women's Hospital
Trastuzumab
Oncology
Internal medicine
Medicine
Physical therapy
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin® and US-Herceptin® in healthy male subjects.
2021
Pharmacology Research & Perspectives
Martin Demarchi
Pierre Coliat
Kristi Mclendon
Jocelyn hii
Peggy Feyaerts
Felicia Ang
Litha Jaison
Filip Deforce
Marie Paule Derde
Michael Jinwoo Kim
Lisa Soyeon Park
Alexandre Detappe
Xavier Pivot
Show All
Source
Cite
Save
Citations (0)
Establishing analytical and clinical similarity between HD201 and herceptin.
2020
Journal of Clinical Oncology
Jocelyn hii
Xavier Pivot
Kristi Mclendon
Kuo Wei Chan
Peggy Feyaerts
Jeong Hyeon Lee
Felicia Ang
Martin Demarchi
Pierre Coliat
Filip Deforce
Marie_Paule Derde
Michael J. Kim
Lisa Soyeon Park
Show All
Source
Cite
Save
Citations (0)
1